Dr Yasmeen Mahmood Butt, MD | |
13400 E Shea Blvd, Scottsdale, AZ 85259-5452 | |
(480) 301-8000 | |
Not Available |
Full Name | Dr Yasmeen Mahmood Butt |
---|---|
Gender | Female |
Speciality | Pathology |
Experience | 11 Years |
Location | 13400 E Shea Blvd, Scottsdale, Arizona |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1134567829 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207ZP0105X | Pathology - Clinical Pathology/laboratory Medicine | 58445 (Arizona) | Primary |
207ZP0101X | Pathology - Anatomic Pathology | 58445 (Arizona) | Secondary |
Facility Name | Location | Facility Type |
---|---|---|
Mayo Clinic Hospital | Phoenix, AZ | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Mayo Clinic - Arizona | 7012829930 | 1395 |
News Archive
Starting in 2017, researchers will commence their study in Eindhoven on the effects of days with high air pollution on respiratory complaints, medication use and lung function of children suffering from chronic respiratory complaints such as wheezing or asthma.
A transgender man in his 30's was able to carry a child after taking female hormones to reverse the effects of his female-to-male sex change treatment. The man from the West Midlands, UK is in a long-term relationship. It is not clear whether his partner is male or female. Medical ethics experts have called for a full inquiry into the issues surrounding transgender births, saying the interests of the child should not be risked to "fulfill the rights of an adult".
A clinical trial of the use of adrenaline in cardiac arrests has found that its use results in less than 1% more people leaving hospital alive - but almost doubles the risk of severe brain damage for survivors of cardiac arrest.
A variant of the dopamine receptor gene may be associated with attention-deficit/hyperactivity disorder (ADHD) and with thinner tissue in areas of the brain that handle attention, but also appears associated with better clinical outcomes among individuals with the disorder, according to a report in the August issue of Archives of General Psychiatry , one of the JAMA/Archives journals.
The Dompé biopharmaceutical company announced today that the Committee for Orphan Medicinal Products of the European Medicines Agency (EMA) has officially designated recombinant human Nerve Growth Factor (rhNGF) - the investigational biotech molecule developed by Dompé based on research by Nobel Laureate Rita Levi Montalcini - as an orphan drug for the treatment of neurotrophic keratitis.
› Verified 2 days ago
Entity Name | Mayo Clinic Arizona |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1558332494 PECOS PAC ID: 7012829930 Enrollment ID: O20031105000782 |
News Archive
Starting in 2017, researchers will commence their study in Eindhoven on the effects of days with high air pollution on respiratory complaints, medication use and lung function of children suffering from chronic respiratory complaints such as wheezing or asthma.
A transgender man in his 30's was able to carry a child after taking female hormones to reverse the effects of his female-to-male sex change treatment. The man from the West Midlands, UK is in a long-term relationship. It is not clear whether his partner is male or female. Medical ethics experts have called for a full inquiry into the issues surrounding transgender births, saying the interests of the child should not be risked to "fulfill the rights of an adult".
A clinical trial of the use of adrenaline in cardiac arrests has found that its use results in less than 1% more people leaving hospital alive - but almost doubles the risk of severe brain damage for survivors of cardiac arrest.
A variant of the dopamine receptor gene may be associated with attention-deficit/hyperactivity disorder (ADHD) and with thinner tissue in areas of the brain that handle attention, but also appears associated with better clinical outcomes among individuals with the disorder, according to a report in the August issue of Archives of General Psychiatry , one of the JAMA/Archives journals.
The Dompé biopharmaceutical company announced today that the Committee for Orphan Medicinal Products of the European Medicines Agency (EMA) has officially designated recombinant human Nerve Growth Factor (rhNGF) - the investigational biotech molecule developed by Dompé based on research by Nobel Laureate Rita Levi Montalcini - as an orphan drug for the treatment of neurotrophic keratitis.
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Yasmeen Mahmood Butt, MD 13400 E Shea Blvd, Scottsdale, AZ 85259-5452 Ph: (480) 301-8000 | Dr Yasmeen Mahmood Butt, MD 13400 E Shea Blvd, Scottsdale, AZ 85259-5452 Ph: (480) 301-8000 |
News Archive
Starting in 2017, researchers will commence their study in Eindhoven on the effects of days with high air pollution on respiratory complaints, medication use and lung function of children suffering from chronic respiratory complaints such as wheezing or asthma.
A transgender man in his 30's was able to carry a child after taking female hormones to reverse the effects of his female-to-male sex change treatment. The man from the West Midlands, UK is in a long-term relationship. It is not clear whether his partner is male or female. Medical ethics experts have called for a full inquiry into the issues surrounding transgender births, saying the interests of the child should not be risked to "fulfill the rights of an adult".
A clinical trial of the use of adrenaline in cardiac arrests has found that its use results in less than 1% more people leaving hospital alive - but almost doubles the risk of severe brain damage for survivors of cardiac arrest.
A variant of the dopamine receptor gene may be associated with attention-deficit/hyperactivity disorder (ADHD) and with thinner tissue in areas of the brain that handle attention, but also appears associated with better clinical outcomes among individuals with the disorder, according to a report in the August issue of Archives of General Psychiatry , one of the JAMA/Archives journals.
The Dompé biopharmaceutical company announced today that the Committee for Orphan Medicinal Products of the European Medicines Agency (EMA) has officially designated recombinant human Nerve Growth Factor (rhNGF) - the investigational biotech molecule developed by Dompé based on research by Nobel Laureate Rita Levi Montalcini - as an orphan drug for the treatment of neurotrophic keratitis.
› Verified 2 days ago
Hany Kamel, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 6210 E Oak St, Scottsdale, AZ 85257 Phone: 800-288-2199 | |
Richard A Bernert, MD Pathology Medicare: Medicare Enrolled Practice Location: 9060 E Via Linda # 9098, Scottsdale, AZ 85258 Phone: 480-275-2494 | |
Dr. Shem Altman, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 10505 N 69th St, Suite 600, Scottsdale, AZ 85253 Phone: 480-629-4008 | |
Steven D Gurley, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 9003 E Shea Blvd, Scottsdale, AZ 85260 Phone: 480-323-3383 Fax: 480-323-3358 | |
Dr. Florencia Anatelli, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 5010 E Shea Blvd Ste 130, Scottsdale, AZ 85254 Phone: 602-494-1817 Fax: 602-494-7103 | |
Matthew James Horne, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 8035 N 85th Way, Scottsdale, AZ 85258 Phone: 203-688-2259 | |
Carolyn K Pettit, MD Pathology Medicare: Medicare Enrolled Practice Location: 9003 E Shea Blvd, Department Of Pathology, Scottsdale, AZ 85260 Phone: 480-323-3383 Fax: 480-323-3358 |